California Biotech Insights

Biotech Leader Spotlight

Suzanne Vyvoda, Chief Development Operations Officer

February 27, 2025

Suzanne Vyvoda is a seasoned clinical development and operations leader, specializing in optimizing execution strategies across biotech and pharma. Over the past year, she has worked with seed-stage companies as a fractional Chief Development Officer and Chief Operating Officer, guiding them in building scalable operational frameworks and crafting investor-ready clinical development plans. With a reputation for transforming complex clinical and operational challenges into strategic solutions, she helps companies drive efficiency, accelerate growth, and achieve sustainable success.

Biotech Market Update

Latigo $150M Raise, Incyte and Genesis Partnership, Mirum FDA Approval

February 25, 2025

Recent Funding: Perceive Pharma (SF) Closes $15M Series A to Advance Small Molecule Neuroprotective Therapies for Glaucoma Perceive Pharma, a spinout from Perceive Biotherapeutics, secured $15M in Series A funding from Deerfield Management, J&J Innovation, GV, and others to develop small-molecule neuroprotective treatments for glaucoma and additional diseases. Lead candidate PBI-671 aims to address glaucoma-related […]

Biotech Market Update

Prebys Ventures $50M Fund, Encoded Layoffs, Aardvark IPO

February 18, 2025

Recent Funding: Prebys Ventures Launches $50 Million Impact Fund to Support San Diego’s Life Sciences & Tech Startups A $50 million investment fund focused on advancing innovation in San Diego, particularly in early-stage life sciences companies, aligning with the Prebys Foundation’s mission in health, research, and innovation. Mike Krenn, CEO of Connect San Diego, will […]

Biotech Market Update

Viracta & Frontier lay offs, Alumis & ACELYRIN merger, Bioluminescence closes

February 11, 2025

Recent Layoffs Viracta Therapeutics (SD) to Cease Operations, Lays Off Entire Workforce Viracta Therapeutics, a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, announced today that the Company has terminated its employees and will wind down operations and lay off all 16 employees. The company seeks […]

Biotech Market Update

Curie.Bio raises $340M, Zentalis lay offs, Metsera & Maze IPOs

February 4, 2025

Recent Funding: Blackstone (NY) Raises Multi-Billion-Dollar Life Sciences Fund for Biotech Investments Blackstone is raising another life sciences fund, targeting at least $5 billion, following its previous 2020 fund. Initial closings have already secured $1.6 billion. The firm continues its strategy of large-scale investments, backing late-stage programs such as Moderna’s flu vaccines ($750M), Alnylam’s RNAi […]

Biotech Research Blogs

Key Insights from the JP Morgan Healthcare Conference 2025

January 29, 2025

A comprehensive analysis of the 2025 JP Morgan Healthcare Conference, covering AI innovations, healthcare partnerships, IPO trends, and regulatory changes in the healthcare industry, with insights from industry leaders: